Here's Why Shareholders May Want To Be Cautious With Increasing AC Immune SA's (NASDAQ:ACIU) CEO Pay Packet [Yahoo! Finance]
AC Immune SA (ACIU)
Last ac immune sa earnings: 11/13 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
acimmune.com/en/investors
Company Research
Source: Yahoo! Finance
Total compensation is similar to the industry average Over the past three years, AC Immune's EPS grew by 15% and over the past three years, the total loss to shareholders 46% In the past three years, the share price of AC Immune SA NASDAQ:ACIU ) has struggled to grow and now shareholders are sitting on a loss. However, what is unusual is that EPS growth has been positive, suggesting that the share price has diverged from fundamentals. The AGM coming up on the 20th of June could be an opportunity for shareholders to bring these concerns to the board's attention. They could also influence management through voting on resolutions such as executive remuneration. We discuss below why we think shareholders should be cautious of approving a raise for the CEO at the moment. View our latest analysis for AC Immune Comparing AC Immune SA's CEO Compensation With The Industry According to our data, AC Immune SA has a market capitalization of US$444m, and paid its CEO total annual compen
Show less
Read more
Impact Snapshot
Event Time:
ACIU
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACIU alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACIU alerts
High impacting AC Immune SA news events
Weekly update
A roundup of the hottest topics
ACIU
News
- Takeda Signs Option to Market Ascentage's Blood-Cancer Drug [BNN Bloomberg (Canada)]BNN Bloomberg
- Blood Brain Barrier Market Untapped Growth Opportunities Analysis - Latest Report by InsightAce Analytic Pvt. Ltd. [Yahoo! Finance]Yahoo! Finance
- AC Immune SA (NASDAQ:ACIU): Are Analysts Optimistic? [Yahoo! Finance]Yahoo! Finance
- AC Immune SA (NASDAQ: ACIU) is now covered by analysts at BTIG Research. They set a "buy" rating and a $8.00 price target on the stock.MarketBeat
- AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024 [Yahoo! Finance]Yahoo! Finance
ACIU
Earnings
- 5/13/24 - Miss
ACIU
Sec Filings
- 6/20/24 - Form 6-K
- 5/21/24 - Form 6-K
- 5/16/24 - Form 144
- ACIU's page on the SEC website